t:connect mobile app used in conjunction with t:slim X2… recallZ-1609-2024 · Tandem Diabetes Care, Inc. · initiated Mar 5, 2024
Open, Classified
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Tandem Diabetes Care, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result in pump battery drain and may lead to the pump shutting down sooner than typically expected. Pump shutdown will cause insulin delivery to suspend, which could lead to an under-delivery of insulin and may result in hyperglycemia, including severe hyperglycemia.
FDA root cause category: Software Design Change
What the company is doing
On 10/09/2024, Tandem send via email an "URGENT MEDICAL DEVICE CORRECTION UPDATE" informing customers of additional actions required (uninstall and reinstall mobile app version 2.8.2) to address the faster than expected battery depletion issue. Customers are instructed to: 1.Touch and hold the app icon. 2.Tap Remove App, then tap Delete App to confirm. 3.Go to Apple App Store. 4.Search t:connect mobile to locate the t:connect mobile app. 5.Tap Download, or the cloud icon with an arrow. 6.Login with your t:connect account credentials and re-pair with your Tandem t:slim X2 pump. For complete re-pair instructions, please visit our website here. Between the dates of August 9-12, 2024, Tandem issued a Press Release and sent an "URGENT MEDICAL DEVICE CORRECTION UPDATE" Letter due to becoming aware that users may still be experiencing pump battery depletion after updating the mobile app to version 2.7.1. On August 19, 2024, Tandem issued a press release announcing the future release of the next version of the t:connect mobile app version 2.8.2. On August 20, 2024, Tandem sent a follow-up email and in-app push notification to all affected users who Tandem has a valid email announcing the release of T:connect mobile app version 2.8.2. - The customer email communication will include a URL and QR code to provide a method for users to acknowledge receipt. Between the dates of August 21, 2024 - September 4, 2024, Tandem will send an "Urgent Medical Device Correction Update" to all affected app users via First-Class Postal mail. This notification will outline the release of T:connect mobile app version 2.8.2.
Recall details
- Recall number
- Z-1609-2024
- Status
- Open, Classified
- Initiated by the company
- Mar 5, 2024
- Posted by the FDA
- May 6, 2024
- Recalling firm
- Tandem Diabetes Care, Inc.
- Quantity
- 85,863 applications
- Product code
- QFG
- FDA submissions
- K203234
- Distribution
- US nationwide distribution including Puerto Rico.
Product description
t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology
Code information (models, lots, serial numbers)
version 2.7 or later /UDI: 00850006613274
Devices named in this recall
1 device in the FDA device registry whose identifier appears in the recall's code information.
- t:connect Mobile Application (iOS) 1004128Tandem Diabetes Care, Inc. · Continuous Glucose Monitor Secondary Display1 recall0 reports
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page